5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between geographic access to cancer care and receipt of chemotherapy: Geographic distribution of oncologists and travel distance
    Meeting Abstract

    Lin, C. C.; Bruinooge, S. S.; Kirkwood, K. M.; Olsen, C. C.; Bajorin, D. F.; Jemal, A.; Giordano, S. H.; Goldstein, M.; Guadagnolo, B. A.; Kosty, M. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Novel chromosome copy number changes to predict clinical response to sunitinib in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Motzer, R.; Hoetker, A.; Akin, O.; Molina, A. M.; Gold, T. M.; Patil, S.; Gowrishankar, B.; Houldsworth, J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Intra-patient genomic heterogeneity of single circulating tumor cells (CTCs) associated to phenotypic CTC heterogeneity in metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Landers, M.; Greene, S.; Schreiber, N. A.; Rodriguez, A.; Bambury, R. M.; Danila, D. C.; Rathkopf, D. E.; Fleisher, M.; Louw, J.; Jendrisak, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Final overall survival analysis for the RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC (mRCC)
    Meeting Abstract

    Knox, J. J.; Barrios, C. H.; Kim, T. M.; Cosgriff, T.; Srimuninnimit, V.; Pittman, K. B.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; Page, R. D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors
    Meeting Abstract

    Infante, J. R.; Naing, A.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Wong, D. J. L.; Falchook, G. S.; Patel, M. R.; Pant, S.; Whiteside, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next generation sequencing (NGS): Results from RECORD-3
    Meeting Abstract

    Hsieh, J.; Chen, D.; Wang, P.; Chen, Y. B.; Redzematovic, A.; Marker, M.; Patel, P.; Chevinsky, M.; Bhanot, U.; Pinciroli, P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J. F.; Arcila, M. E.; Cheng, D. T.; Solit, D. B.; Yaeger, R. D.; Hyman, D. M.; Berger, M. F.; Shia, J.; Vakiani, E.; Zehir, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy for residual disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)
    Meeting Abstract

    Harshman, L. C.; Werner, L.; Wong, Y. N.; Yu, E. Y.; Alva, A. S.; Crabb, S. J.; Powles, T.; Rosenberg, J. E.; Baniel, J.; Vaishampayan, U. N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Hammers, H. J.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D. F.; Ernstoff, M.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A. R. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • CheckMate 214: A phase III, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in patients with previously untreated metastatic renal cell carcinoma
    Meeting Abstract

    Hammers, H. J.; Plimack, E. R.; Sternberg, C.; McDermott, D. F.; Larkin, J. M. G.; Ravaud, A.; Rini, B. I.; Sharma, P.; Bhagavatheeswaran, P.; Gagnier, P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save